Журнал включен в российские и международные библиотечные и реферативные базы данных
РИНЦ (Россия)
RINZ (RUSSIA)
Регистрационное агентство DOI (США)
DOI Registration Agency (USA)
Эко-Вектор (Россия)
Eco-Vector (Russia)
Ulrichsweb (Ulrich’s Periodicals Director

Osteoporosis: prevention of fractures with OSTEOMED FORTE by PARAFARM

DOI: https://doi.org/10.29296/25879979-2022-08-02
Download full text PDF
Issue: 
8
Year: 
2022

M.D. Kashpanov, V.V. Popov, I.A. Novikova
Northern State Medical University, Arkhangelsk, Russia

Objective of the study. To study the literature data on the problem of osteoporosis and prevention of osteoporotic fractures with the help of “Osteomed forte” by “Parafarm”. Material and methods. Analysis of the literature data about osteoporosis and prophylaxis of osteoporosis fractures with the help of “Osteomed forte” by “Parafarm” was carried out. Results and discussion. A dynamic growth of osteoporosis incidence in many countries was noted. Obtained a direct link between osteoporosis fractures and cardiovascular risk in men and women. They showed that the most severe and costly of all osteoporotic fractures is the fracture of the proximal femur. This is associated with frequent disability and high mortality of patients at both hospital and outpatient stages of care. We’ve found out that Osteomed Forte (manufacturer - Parafarm, Russia) is one of the most effective drugs which allows to make the bones grow together in optimal terms and accelerate the process of rehabilitation after osteoporosis fracture. Conclusions. Thus, the use of the drug Osteomed Forte by “Parafarm” (Russia) can be recommended in patients with osteoporosis for prevention of osteoporosis fractures with taking into account the personalized approach while choosing treatment tactics of a patient.
Keywords: 
osteoporosis
fractures
prevention
Osteomed forte
Parafarm
nursing

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Melnichenko G.A., Belaya J.E., Rozhinskaya L.Y. et al. Federal clinical guidelines for the diagnosis, treatment and prevention of osteoporosis. Problems of Endocrinology, 2017; 63 (6): 392–426. DOI: 10.14341/probl2017636392-426
  2. Yarikov A.V., Smirnov I.I., Pavlinov S.E. et al. Osteoporosis of the spine: epidemiology, modern methods of diagnosis and principles of treatment. Vrach, 2020; 31 (11): 21–28. DOI: 10.29296/25877305-2020-11-04
  3. Shishkova V.N., Kosmatova O.V., Skripnikova I.A. et al. Topical issues of diagnosis and therapy of osteoporosis in the practice of the therapist. Medical Business, 2021; 1: 52–61. DOI: 10.24412/2071-5315-2021-12284
  4. Myagkova M.A., Skripnikova I.A., Shalnova S.A.. Associations of 10-year probability of osteoporotic fractures with total cardiovascular risk and cardiovascular disease due to atherosclerosis among urban and rural populations. Preventive Medicine, 2021; 24 (6): 18–27. DOI: 10.17116/profmed20212406118
  5. Yarikov A.V., Denisov A.A., Masevnin S.V. et al. Osteoporosis in the practice of the vertebrologist. Vrach, 2020; 31 (3): 11–18. DOI: 10.29296/25877305-2020-03-02
  6. Dedov D.V. Osteoporosis in elderly patients: prevalence, pathogenesis, clinic, prevention of complications. Vrach, 2021; 32 (7): 82–85. DOI: 10.29296/25877305-2021-07-14
  7. Skripnikova I.A., Guryev A.V., Shalnova S.A. et al. Prevalence of clinical factors used to assess the risk of osteoporotic fractures. Preventive Medicine, 2016; 5: 32–40. DOI: 10.17116/profmed201619532-40
  8. Pavlova T., Bashuk I. Clinical and morphological features of degenerative changes in bone tissue against osteoporosis in the age aspect. Vrach, 2019; 30 (6): 47–50. DOI: 10.29296/25877305-2019-06-11
  9. Yarmolovich R.A., Salaev A.V. Improvement of regenerative ability of bone tissue at diaphyseal fractures of tubular bones on the background of Osteomed Forte application. Vrach, 2020; 31 (5): 63–66. DOI: 10.29296/25877305-2020-05-14
  10. Strukov V., Elistratov D., Kislov A. et al. Osteoporosis in geriatric practice. Vrach, 2018; 29 (6): 26–30. DOI: 10.29296/25877305-2018-06-05
  11. Romanov D.V., Polikarpochkin A.N., Polikarpochkina E.V. Osteomed Forte in the treatment of patients with ankle injuries. Vrach, 2020; 31 (8): 70–74. DOI: 10.29296/25877305-2020-08-11
  12. Dedov D.V. Secondary osteoporosis in patients with rheumatoid arthritis, prevention of complications with Osteomed, Osteomed Forte, Osteo-Vit D3. Pharmacy, 2022; 71 (3): 5–9. DOI: 10.29296/25419218-2022-03-01
  13. Peshekhonova L.K., Peshekhonov D.V., Krasyukov P.A. Clinical efficacy of Osteomed, Osteomed Forte, Osteo-Vit D3 in patients with secondary osteoporosis in rheumatoid arthritis. Vrach, 2020; 31 (4): 68–74. DOI: 10.29296/25877305- 2020-04-12
  14. Kokoreva I., Korenkov A., Solovyov I. Effect of the drug Osteomed Forte on the consolidation time of bone fractures in children and adolescents. Vrach, 2020; 31 (1): 82–85. DOI: 10.29296/25877305-2020-01-18
  15. Struchkov V.I., Katyushina Yu.G., Eremina N.V., Filippova O.V. Discovery in the treatment of presenile and senile osteoporosis. International Journal of Applied and Fundamental Research. 2013. No. 9.: 122-124
  16. Strukov V.I., Prokhorov M.D., Elistratov D.G. A method for reducing the duration of immobilization in bone fractures. International Journal of Applied and Fundamental Research. 2013. No. 9: 124-126.
  17. Strukov V.I., Kislov A.I., Eremina N.V., Deriabina G.P., Sergeeva-Kondrachenko M.Y., Antropov A.Y., Kuzmina Y.V., Tayrova K.R., Petrova E.V., Elistratov D.G., Strukova-Jones O.V. The use of bone tissue non-steroid anabolizators in treatment of osteoporosis. Research Journal of Pharmacy and Technology. 2019. Vol. 12. No. 5: 2195-2199
  18. Biryukova O.A., Vinogradova O.P., Korshunov G.V., Podymkina A.V. Diagnosis of the severity of inflammatory diseases of the pelvic organs by markers of hemostasis and inflammation. Modern studies of social problems (electronic scientific journal). 2014. No. 9: 49-61.
  19. Ostanina Yu.A., Ostanin A.A., Vinogradova O.P., Arsenyeva L.S. Changes in the hemostasis system in inflammatory diseases of the pelvic organs. Thrombosis, hemostasis and rheology. 2009. No. 2 (38): 64-68.
  20. Dorogova I.V., Bartosh L.F., Panina E.S. Development of general medical practice in the Penza region. General Practitioner’s Handbook. 2014. No. 1: 49-52.
  21. Petrova E.V., Panina E.S., Rodina O.P., Poluboyarinov P.A., Radchenko L.G., Galeeva R.T., Musatova L.A. Modern approaches to the prevention and treatment of fractures in osteoporosis. A nurse. 2020. Vol. 22. No. 3: 29-33.
  22. Poluboyarinov P.A., Elistratov D.G. Innovations of the company «Parapharm» in the cultivation of medicinal plants and their processing. A nurse. 2022. Vol. 24. No. 7: 27-30.
  23. Moiseeva I.Ya., Sergeeva-Kondrachenko M.Yu., Strukov V.I., Vinogradova O.P., Petrova E.V., Panina E.S., Rodina O.P., Poluboyarinov P.A., Elistratov D.G. Prospects for the use of osteobiotic drugs in antibacterial therapy. Therapist. 2022. No. 10: 31-37.